Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformite Europeenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management. ...
A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy individuals with a higher risk of cancer based on a simple blood dra ...